Lineage Cell Therapeutics, Inc. (LCTX) KPIs and segments
Close on Nov 13, 2026Market cap $231.31MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Lineage Cell Therapeutics's business
Lineage Cell Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Collaborative Revenue($M) | 1.78 | 0 | |||||||||||
Collaboration Revenues($M) | 0.94 | 1.58 | 6.26 | 3.54 | 2.53 | 1.27 | 2.48 | 3.39 | 1.10 | 1.19 | 1.64 | 0.96 | |
Upfront License Fees($M) | 0.60 | 0.86 | 0.88 | 1.76 | 2.53 | 1.27 | 2.48 | 3.39 | 1.10 | 1.19 | 1.64 | 0.96 | |
Event Based Milestones and Other Collaborative Revenue($M) | 0.34 | 0.72 | |||||||||||
Royalties, License and Other Revenues($M) | 0.13 | 0.15 | 0.35 | 0.14 | 0.23 | 0.23 | 0.39 | 0.39 | 0.31 | 0.26 | 0.45 | 0.29 | |
5 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?